Cargando…
Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection
Coronavirus−19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite advances in therapy, social distancing, masks, and vaccination many places in the world continue to see an increase in the number of cases and deaths. Viremia is co...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531584/ https://www.ncbi.nlm.nih.gov/pubmed/34692735 http://dx.doi.org/10.3389/fmed.2021.744141 |
_version_ | 1784586891356536832 |
---|---|
author | Amundson, Dennis E. Shah, Usman S. de Necochea-Campion, Rosalia Jacobs, Michael LaRosa, Steven P. Fisher, Charles J. |
author_facet | Amundson, Dennis E. Shah, Usman S. de Necochea-Campion, Rosalia Jacobs, Michael LaRosa, Steven P. Fisher, Charles J. |
author_sort | Amundson, Dennis E. |
collection | PubMed |
description | Coronavirus−19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite advances in therapy, social distancing, masks, and vaccination many places in the world continue to see an increase in the number of cases and deaths. Viremia is commonly present in severely ill patients with COVID-19 infections and is associated with organ dysfunction and poor outcomes. Exosomes released by activated cells have been implicated in the pathogenesis of COVID-19 infection. We report the experience of two cases of critically ill COVID-19 patients treated with the Hemopurifier; a lectin affinity cartridge designed to remove mannosylated viruses and exosomes. Both patients tolerated the Hemopurifier sessions without adverse effects. In the first patient removal of exosomes and exosomal microRNAs was associated with improved coagulopathy, oxygenation, and clinical recovery, while in a second patient removal of COVID-19 by the Hemopurifier cartridge was observed. The Hemopurifier is currently under further investigation in up to 40-patients in a safety and feasibility study in ICU patients with COVID-19 infection. |
format | Online Article Text |
id | pubmed-8531584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85315842021-10-23 Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection Amundson, Dennis E. Shah, Usman S. de Necochea-Campion, Rosalia Jacobs, Michael LaRosa, Steven P. Fisher, Charles J. Front Med (Lausanne) Medicine Coronavirus−19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite advances in therapy, social distancing, masks, and vaccination many places in the world continue to see an increase in the number of cases and deaths. Viremia is commonly present in severely ill patients with COVID-19 infections and is associated with organ dysfunction and poor outcomes. Exosomes released by activated cells have been implicated in the pathogenesis of COVID-19 infection. We report the experience of two cases of critically ill COVID-19 patients treated with the Hemopurifier; a lectin affinity cartridge designed to remove mannosylated viruses and exosomes. Both patients tolerated the Hemopurifier sessions without adverse effects. In the first patient removal of exosomes and exosomal microRNAs was associated with improved coagulopathy, oxygenation, and clinical recovery, while in a second patient removal of COVID-19 by the Hemopurifier cartridge was observed. The Hemopurifier is currently under further investigation in up to 40-patients in a safety and feasibility study in ICU patients with COVID-19 infection. Frontiers Media S.A. 2021-10-08 /pmc/articles/PMC8531584/ /pubmed/34692735 http://dx.doi.org/10.3389/fmed.2021.744141 Text en Copyright © 2021 Amundson, Shah, de Necochea-Campion, Jacobs, LaRosa and Fisher. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Amundson, Dennis E. Shah, Usman S. de Necochea-Campion, Rosalia Jacobs, Michael LaRosa, Steven P. Fisher, Charles J. Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection |
title | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection |
title_full | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection |
title_fullStr | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection |
title_full_unstemmed | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection |
title_short | Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection |
title_sort | removal of covid-19 spike protein, whole virus, exosomes, and exosomal micrornas by the hemopurifier® lectin-affinity cartridge in critically ill patients with covid-19 infection |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531584/ https://www.ncbi.nlm.nih.gov/pubmed/34692735 http://dx.doi.org/10.3389/fmed.2021.744141 |
work_keys_str_mv | AT amundsondennise removalofcovid19spikeproteinwholevirusexosomesandexosomalmicrornasbythehemopurifierlectinaffinitycartridgeincriticallyillpatientswithcovid19infection AT shahusmans removalofcovid19spikeproteinwholevirusexosomesandexosomalmicrornasbythehemopurifierlectinaffinitycartridgeincriticallyillpatientswithcovid19infection AT denecocheacampionrosalia removalofcovid19spikeproteinwholevirusexosomesandexosomalmicrornasbythehemopurifierlectinaffinitycartridgeincriticallyillpatientswithcovid19infection AT jacobsmichael removalofcovid19spikeproteinwholevirusexosomesandexosomalmicrornasbythehemopurifierlectinaffinitycartridgeincriticallyillpatientswithcovid19infection AT larosastevenp removalofcovid19spikeproteinwholevirusexosomesandexosomalmicrornasbythehemopurifierlectinaffinitycartridgeincriticallyillpatientswithcovid19infection AT fishercharlesj removalofcovid19spikeproteinwholevirusexosomesandexosomalmicrornasbythehemopurifierlectinaffinitycartridgeincriticallyillpatientswithcovid19infection |